DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20214277

A study on awareness on allergic disorders and allergen immunotherapy among medical practitioners

Giriyanna Gowda, Pruthvi S., M. S. Phaneendra, Chitra Nagaraj

Abstract


Background: Allergy is a common ailment affecting more than 20% of the population worldwide. Allergic patients suffer from a debilitating disease with a major impact on their quality of life, work and school performance. Allergic disorders can be debilitating, with a major impact on their quality of life, work and school performance. AIT (Allergen immunotherapy), modify the natural history of allergic disease and prevent the progression of allergic respiratory diseases by maintaining a long-lasting effect. Since the awareness among medical practitioners plays very important role in advising AIT for allergy patients, we attempted to conduct this study.

Methods: This was a descriptive study done for a period of three months from December 2016 to February 2017. The 110 study subjects were recruited through purposive sampling. Doctors of various specialties and general practitioners were interviewed using self-administered, semi-structured questionnaire.

Results: There were 73 (66.36%) males and 37 (33.64%) females. Mean age of the medical practitioners was 35.73±13.07 (Mean±SD). 98 (89.09%) of the practitioners were aware of skin prick test for the diagnosis of allergy, 70 (63.3%) subjects had heard term AIT, 59 (84.28%) were aware about subcutaneous immunotherapy (SCIT) and 25 (35.71%) of sublingual immunotherapy (SLIT). Forty-four (62.96%) were not advising immunotherapy for their patients in spite of having awareness on immunotherapy. The common reasons for not advising immunotherapy were long duration of treatment, high cost, less effective, not available in India, fear of side effects and others.

Conclusions: Though the awareness among medical practitioners on AIT was good, majority are not advising because of long duration of treatment, high cost, less effective, not available in India, fear of side effects and others.


Keywords


Allergic disorders, AIT, Awareness, SCIT, SLIT

Full Text:

PDF

References


Pawankar R, Caninica GW, Holgate ST, Lockey RF. World Allergy Organization white book on allergy 2013 update. World Allergy Org. 2013;118-9.

Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi-country cross-sectional surveys. Lancet. 2006;368(9537):741-2.

Lombardi C, Bettoncelli G, Canonica GW, Passalacqua G. The perception of allergen-specific immunotherapy among Italian general practitioners. Eur ann allergy clin immunol. 2014;46(2):83-6.

Muraro A, Roberts G. Allergen Immunotherapy Guidelines-Part 2 recommendations. Eur Academy Allergy Clin Immunol. 2017;5-7.

Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I et al. Allergen immunotherapy: A practice parameter third update. J Allergy clin Immunol. 2011;127(1):S1-55.

Landi M, Meglio P, Praitano E, Lombardi C, Passalacqua G, Canonica GW. The perception of allergen-specific immunotherapy among pediatricians in the primary care setting. Clin Molecular Allergy. 2015;13(1):13-7.

Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950-8.

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. 2018;47.

Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK et al. Articles Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi-country cross-sectional surveys. Lancet. 2006;368(9537):733-43.

Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104(2):301-4.

Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: Data from the second National Health and Nutrition Examination Survey, 1976-1980 (NHANES II). J Allergy Clin Immunol. 1992;90(4):579-88.

Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992;90(2):250-6.

Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database of Systematic Reviews. Cochrane Database Syst Rev. 2003;(4):CD003570.

Zuberbier T, Lötvall J, Simoens S, Subramanian SV. Church MK. Economic burden of inadequate management of allergic diseases in the European Union: A GA2LEN review. Allergy: Eur J Allergy Clin Immunol. 2014;69(10):1275-9.